secondary

Junshi Biosciences Announces the Phase 3 Study of JS005 (IL-17A) for the Treatment of Moderate to Severe Plaque Psoriasis Met Primary Endpoints

SHANGHAI, Sept. 07, 2025 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading…

2 weeks ago

Cango Inc. Announces Completion of Secondary Acquisition and Appointment of New Leadership Team

HONG KONG, July 23, 2025 /PRNewswire/ -- Cango Inc. (NYSE: CANG) today announced its transformation into a global Bitcoin miner…

2 months ago

Cango Inc. Announces Results of Second Extraordinary General Meeting

HONG KONG, July 17, 2025 /PRNewswire/ -- Cango Inc. (NYSE: CANG) ("Cango" or the "Company") today announced that all resolutions…

2 months ago

MSP Recovery Law Firm Secures Major Legal Win for MSP Recovery as Maryland Supreme Court Upholds Validity of Medicare Recovery Assignments for MSP Recovery and Its Healthcare Clients, Paving the Way for Medicare Recovery Rights Being Pursued Against GEICO

MIAMI, July 12, 2025 (GLOBE NEWSWIRE) -- MSP Recovery Law Firm, counsel to MSP Recovery and its affiliated healthcare clients,…

2 months ago